JP2020508961A5 - - Google Patents

Info

Publication number

JP2020508961A5

JP2020508961A5 JP2018547979A JP2018547979A JP2020508961A5 JP 2020508961 A5 JP2020508961 A5 JP 2020508961A5 JP 2018547979 A JP2018547979 A JP 2018547979A JP 2018547979 A JP2018547979 A JP 2018547979A JP 2020508961 A5 JP2020508961 A5 JP 2020508961A5

Authority

JP

Japan

Prior art keywords

pharmaceutical composition

composition according

dose

administered

day

Prior art date

2018-03-02

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 208000008589 Obesity Diseases 0.000 claims description 6
• 235000020824 obesity Nutrition 0.000 claims description 6
• XFJAMQQAAMJFGB-ZQGJOIPISA-N (2s,3r,4r,5s,6r)-2-[3-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-4-ethylphenyl]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound C1=C(CC=2C=C3OCCOC3=CC=2)C(CC)=CC=C1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XFJAMQQAAMJFGB-ZQGJOIPISA-N 0.000 claims description 4
• 206010012735 Diarrhoea Diseases 0.000 claims description 4
• 150000003839 salts Chemical class 0.000 claims description 4
• 208000016261 weight loss Diseases 0.000 claims description 4
• 230000004580 weight loss Effects 0.000 claims description 4
• 239000002552 dosage form Substances 0.000 claims description 3
• 230000037396 body weight Effects 0.000 claims description 2
• 239000008194 pharmaceutical composition Substances 0.000 claims 14